Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective Council Decision

Rozhodnutie č. 185/2004

Text language

Important dates

Declared: 19. februára 2004
Approved: 19. februára 2004
Effective from: 15. marca 2004
Effective until: 31. decembra 2007

Documents and links

Council Decision

of 19 February 2004

concerning the adoption of a supplementary research programme to be implemented by the Joint Research Centre for the European Atomic Energy Community

(2004/185/Euratom)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty establishing the European Atomic Energy Community, and in particular Article 7 thereof,

Having regard to the proposal from the Commission submitted after consultation of the Scientific and Technical Committee,

Having regard to the opinion of the Board of Governors of the Joint Research Centre (JRC),

Whereas:

(1) Within the framework of the European research area, the supplementary research programme involving the high flux reactor (HFR) is one of the principal means available in the Union to contribute to safe nuclear technologies, to materials research for thermonuclear fusion, to fundamental research, to medical research and medical applications and to training in these areas.

(2) The financial contributions to this supplementary programme will come directly from the Netherlands and France,

HAS ADOPTED THIS DECISION:

Article 1

The supplementary research programme on the operation of HFR, hereinafter referred to as "the programme", the objectives of which are set out in Annex I, is hereby adopted for a period of three years, starting on 1 January 2004.

Article 2

The financial contributions estimated as necessary for the execution of the programme amount to about EUR 30,6 million. The breakdown of the contributions is given in Annex II. It includes provision for the reactor decommissioning.

Article 3

The Commission shall be responsible for the implementation of the programme, and to this end, shall call upon the services of the JRC. The JRC Board of Governors shall be kept informed about the implementation of the programme.

Article 4

The Commission shall each year, before 15 June, submit to the European Parliament, to the Council and to the European Economic and Social Committee a report on the implementation of this Decision.

Article 5

This Decision is addressed to the Member States.

Done at Brussels, 19 February 2004.

For the Council

The President

M. McDowell

ANNEX I

SCIENTIFIC AND TECHNICAL OBJECTIVES

The programme's aims are primarily:

1. To provide more than 250 days per year of operation of the HFR in order to guarantee availability of neutrons for experiments.

2. To allow for the rational use of this reactor according to the needs of research institutions requiring HFR support in areas such as: improvement of safety of existing nuclear reactors, health, including the development of medical isotopes to answer the questions of medical research and the testing of medical therapeutic techniques, fusion, fundamental research and training and waste management, including the possibility of developing nuclear fuel devoted to the elimination of weapon-grade plutonium.

ANNEX II

BREAKDOWN OF THE CONTRIBUTIONS

The contributions to the programme will come from the Netherlands and France.

The breakdown of these contributions is as follows:

The Netherlands: EUR 29,75 million

France: EUR 0,90 million

Total: EUR 30,65 million